98%
921
2 minutes
20
Sex-dependent differences in immunity and coagulation play an active role in the outcome of community-acquired pneumonia (CAP). Contact phase proteins act at the crossroads between inflammation and coagulation thus representing a point of convergence in host defense against infection. Here, we measured the levels of factor XII (FXII), FXIIa-C1 esterase inhibitor (C1INH) complexes, and high-molecular-weight kininogen (HK) in plasma of patients with CAP and correlated them to clinical disease severity. Levels of FXIIa-C1INH/albumin ratio were elevated, irrespective of sex, in plasma of patients with CAP ( = 139) as compared with age-matched donors ( = 58). No simultaneous decrease in FXII levels, indicating its consumption, was observed. Stratification by sex revealed augmented FXII levels in plasma of women with CAP as compared with sex-matched donors yet no apparent differences in men. This sex-specific effect was, however, attributable to lower FXII levels in female donors relative to men donors. Plasma estradiol levels mirrored those for FXII. Levels of HK/albumin ratio were decreased in CAP plasma as compared with donors, however, after stratification by sex, this difference was only observed in women and was related to higher HK/albumin values in female donors as opposed to male donors. Finally, strong negative correlation between plasma levels of HK/albumin ratio and CAP severity, as assessed by CRB65 score, in males and females was observed. Our study identifies sex-dependent differences in plasma levels of the contact phase proteins in elderly subjects that may contribute to specific clinical outcomes in CAP between men and women.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1152/ajplung.00162.2021 | DOI Listing |
Thromb Res
September 2025
The Coagulation Unit, Department of Clinical Biochemistry, Aalborg University Hospital, Denmark; Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
Introduction: Combined oral contraceptives (COC) are associated with an increased risk of venous thromboembolism (VTE). The contact system (CAS) can, when activated, stimulate coagulation, and may play a role in thrombus formation. Our recent case-control study showed increased CAS capacity and in vivo activity in COC users, indicating a systemic activation that could contribute to VTE risk during COC treatment.
View Article and Find Full Text PDFAm J Reprod Immunol
August 2025
Department of Clinical Biochemistry, University Hospital of Southern Denmark, Esbjerg, Denmark.
Pregnancy loss affects approximately 23% of women, with 1%-3% experiencing recurrent pregnancy loss (RPL), defined as two or more consecutive miscarriages. Despite extensive research, up to 50% of RPL cases remain unexplained, making it a complex issue in reproductive medicine. Coagulation Factor XII (FXII) a key component of the contact activation pathway, has been suggested to play a role in RPL.
View Article and Find Full Text PDFRes Pract Thromb Haemost
July 2025
Department of Operative Medicine, University Clinic for Anaesthesia and Intensive Medicine, Medical University of Innsbruck, Innsbruck, Austria.
Background: Severe exercise performed over longer duration can involve multiple prothrombotic alterations in blood coagulation markers. Standard coagulation tests are not robust in identifying hyper- or hypocoagulability due to indirect determination of changes in hemostasis and fibrinolysis. Conversely, viscoelastic tests might do so.
View Article and Find Full Text PDFExpert Opin Biol Ther
July 2025
Division of Rheumatology & Clinical Immunology, Department of Medicine, University of Hong Kong, Pokfulam, Hong Kong SAR, China.
Introduction: Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of subcutaneous and/or submucosal swelling (angioedema). Current HAE-specific medications primarily focus on either inhibiting plasma bradykinin or kallikrein, or replacing C1-esterase inhibitor, but they are frequently limited in efficacy and accessibility. In contrast, Factor XII (FXII) inhibitors may provide a novel therapeutic approach by targeting the contact system at an upstream level, potentially addressing some of these limitations.
View Article and Find Full Text PDFBr J Hosp Med (Lond)
May 2025
Med-International UK Health Agency Ltd., Leicestershire, UK.
Venous thromboembolism (VTE), which includes pulmonary embolism (PE) and deep vein thrombosis (DVT), is a serious vascular disease that ranks third in cardiovascular-related deaths. Inflammation along with neutrophil extracellular traps (NETs) play a key role in the pathophysiology of VTE. This review focuses on articles that that evaluate the role of NETs in the development of VTE and their potential as therapeutic targets.
View Article and Find Full Text PDF